Cadila Healthcare Ltd. v. Cadila Pharmaceuticals Ltd. (2001)
Supreme Court of India · (2001) 5 SCC 73 · AIR 2001 SC 1952 · Three-Judge Bench · 2001-03-26
Summary
The Supreme Court laid down important principles for assessing deceptive similarity between marks, particularly for medicinal products. Courts must consider overall structural and phonetic similarity and the circumstances of the trade, including the nature of the goods and the characteristics of purchasers. Greater caution is warranted where confusion in medicinal products can have serious consequences.
Facts
- Two pharmaceutical companies used competing marks for medicinal products.
- The dispute concerned whether the defendant’s mark was deceptively similar and likely to cause confusion.
- The Supreme Court considered how similarity should be assessed in the context of medicinal goods and ordinary purchasers.
- The Court also discussed the distinction between infringement of a registered trade mark and passing off.
Issues
- How should deceptive similarity between medicinal trade marks be assessed?
- What factors are relevant to likelihood of confusion among ordinary purchasers?
- How do infringement and passing-off actions differ?
- Should medicinal marks receive stricter scrutiny because confusion may affect health and safety?
Provisions involved
- Trade Marks Act, 1999 — s. 29 — Infringement of registered trade marks
- Trade Marks Act, 1999 — s. 27 — No action for infringement of unregistered trade mark; passing off preserved
Reasoning
Overall comparison
Competing marks should be considered as wholes. Courts should examine overall structural and phonetic similarity rather than dissecting words into isolated components.
Imperfect recollection
The test considers an average purchaser with imperfect recollection and asks whether overall similarity is likely to deceive or cause confusion in the relevant market.
Medicinal products
Because medicinal products affect health, the assessment of confusion requires particular caution. The nature of the goods and characteristics of purchasers are relevant.
Infringement and passing off
Infringement is a statutory remedy protecting a registered mark, while passing off protects against misrepresentation causing or likely to cause damage to goodwill.
Decision
The Supreme Court applied a cautious likelihood-of-confusion approach appropriate to medicinal products and reaffirmed the need to assess marks as a whole in their commercial context.
Ratio decidendi
Likelihood of deception or confusion is assessed by overall similarity and relevant commercial circumstances; medicinal marks require particular caution because confusion can have serious consequences.
Exam points
- Use the overall-impression test rather than dissecting marks into isolated parts.
- Medicinal products require heightened caution when assessing deceptive similarity.
- Distinguish statutory infringement from passing off.
Tags: trademark, passing-off, medicines, deception